Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GR68755 in Japanese Females With Severe Diarrhea-predominant IBS
NCT01855711Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2003
- Primary completion
- May 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Alosetron in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by GSK. Started Sep 2003; status: completed.
02
Drugs
Alosetron
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT01855711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01855711.